Latest1 information on COVID-19

Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants?

Recruiting

I'm Interested

Trial ID: NCT01944696

Purpose

Cycled (intermittent) phototherapy will be compared to continuous (uninterrupted) phototherapy in the treatment of hyperbilirubinemia (newborn jaundice) in extremely low birth weight newborns in a pilot randomized controlled trial. Hypothesis: Cycled phototherapy (PT) will provide the same benefits as continuous phototherapy in extremely low birth weight (ELBW) infants without the risks that have been associated with continuous phototherapy.

Official Title

Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants?

Stanford Investigator(s)

Eligibility


Inclusion Criteria:

   - birth weight 401-1000 grams

   - age less than or equal to 24 hours

Exclusion Criteria:

   - hemolytic disease

   - major anomaly

   - overt nonbacterial infection

Intervention(s):

other: phototherapy

Recruiting

I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
David K Stevenson, MD
497-0735